CIK: 0001056807 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 12, 2021
Total Value ($000): $2,541,924 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OLMA | OLEMA PHARMACEUTICALS INC | 6,661,503 | $320,285 | 12.6% | $46.89 | 0.0% | COM | 68062P106 |
| XOMA | XOMA CORP DEL | 4,182,243 | $184,562 | 7.3% | $15.45 | +95.1% | COM NEW | 98419J206 |
| KYMR | KYMERA THERAPEUTICS INC | 2,630,658 | $163,101 | 6.4% | $30.53 | +59.8% | COM | 501575104 |
| RLAY | RELAY THERAPEUTICS INC | 3,073,147 | $127,720 | 5.0% | $38.13 | +18.6% | COM | 75943R102 |
| RVMD | REVOLUTION MEDICINES INC | 2,768,049 | $109,587 | 4.3% | $30.55 | +29.4% | COM | 76155X100 |
| — | REPARE THERAPEUTICS INC | 2,972,191 | $101,946 | 4.0% | $30.93 | — | COM | 760273102 |
| — | MERUS N V | 5,805,571 | $101,772 | 4.0% | $17.19 | — | COM | N5749R100 |
| CYTK | CYTOKINETICS INC | 4,878,035 | $101,366 | 4.0% | $21.76 | -16.0% | COM NEW | 23282W605 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 4,273,588 | $86,156 | 3.4% | $16.07 | +33.9% | COM | 74366E102 |
| IONS | IONIS PHARMACEUTICALS INC | 1,364,461 | $77,147 | 3.0% | $56.38 | -11.6% | COM | 462222100 |
| RCUS | ARCUS BIOSCIENCES INC | 2,752,222 | $71,448 | 2.8% | $25.42 | -4.8% | COM | 03969F109 |
| XNCR | XENCOR INC | 1,264,754 | $55,181 | 2.2% | $32.68 | +26.6% | COM | 98401F105 |
| XENE | XENON PHARMACEUTICALS INC | 3,499,346 | $53,820 | 2.1% | $11.23 | +4.2% | COM | 98420N105 |
| — | AMARIN CORP PLC | 10,761,593 | $52,624 | 2.1% | $4.82 | — | SPONS ADR NEW | 023111206 |
| ACIU | AC IMMUNE SA | 9,816,658 | $50,752 | 2.0% | $6.68 | -23.6% | SHS | H00263105 |
| ALXO | ALX ONCOLOGY HLDGS INC | 540,837 | $46,620 | 1.8% | $39.31 | +53.0% | COM | 00166B105 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 1,106,070 | $45,847 | 1.8% | $41.28 | 0.0% | COM | 35104E100 |
| IDYA | IDEAYA BIOSCIENCES INC | 3,226,769 | $45,175 | 1.8% | $9.07 | +49.3% | COM | 45166A102 |
| — | ESSA PHARMA INC | 3,705,289 | $44,204 | 1.7% | $5.84 | — | COM NEW | 29668H708 |
| SPRO | SPERO THERAPEUTICS INC | 2,243,278 | $43,497 | 1.7% | $13.39 | +16.5% | COM | 84833T103 |
| KURA | KURA ONCOLOGY INC | 1,245,912 | $40,691 | 1.6% | $12.44 | +182.5% | COM | 50127T109 |
| — | SUTRO BIOPHARMA INC | 1,854,162 | $40,254 | 1.6% | $8.55 | — | COM | 869367102 |
| LXRX | LEXICON PHARMACEUTICALS INC | 10,963,000 | $37,493 | 1.5% | $1.91 | 0.0% | COM NEW | 528872302 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 17,426,968 | $36,945 | 1.5% | $2.67 | -38.3% | COM | 45665G303 |
| CTMX | CYTOMX THERAPEUTICS INC | 5,576,471 | $36,526 | 1.4% | $7.75 | -7.9% | COM | 23284F105 |
| — | GLYCOMIMETICS INC | 9,544,262 | $35,886 | 1.4% | $4.18 | — | COM | 38000Q102 |
| — | FORTE BIOSCIENCES INC | 718,788 | $26,171 | 1.0% | $14.58 | — | COM | 34962G109 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $25,493 | 1.0% | $23.30 | — | SPONSERED ADS | 13124Q106 |
| — | VERASTEM INC | 11,180,994 | $23,816 | 0.9% | $1.80 | — | COM | 92337C104 |
| IMVT | IMMUNOVANT INC | 514,370 | $23,759 | 0.9% | $13.66 | +238.4% | COM | 45258J102 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $22,314 | 0.9% | $3.77 | — | COM | 12648L601 |
| — | CALITHERA BIOSCIENCES INC | 4,361,238 | $21,414 | 0.8% | $4.77 | — | COM | 13089P101 |
| — | MOLECULAR TEMPLATES INC | 2,149,057 | $20,180 | 0.8% | $5.54 | — | COM | 608550109 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 878,524 | $19,538 | 0.8% | $9.34 | +122.1% | COM | 87164F105 |
| ARGX | ARGENX SE | 62,491 | $18,378 | 0.7% | $221.08 | — | SPONSORED ADR | 04016X101 |
| — | FIVE PRIME THERAPEUTICS INC | 1,038,678 | $17,668 | 0.7% | $8.27 | — | COM | 33830X104 |
| COGT | COGENT BIOSCIENCES INC | 1,532,282 | $17,208 | 0.7% | $10.99 | 0.0% | COM | 19240Q201 |
| — | PIERIS PHARMACEUTICALS INC | 5,494,582 | $13,736 | 0.5% | $3.02 | — | COM | 720795103 |
| — | THERAPEUTICS ACQUISITION COR | 954,996 | $13,322 | 0.5% | $14.38 | — | COM CL A | 88339T103 |
| — | NOVUS THERAPEUTICS INC | 763,279 | $11,754 | 0.5% | $15.40 | — | COM | 67011N204 |
| — | GAMIDA CELL LTD | 1,343,667 | $11,273 | 0.4% | $4.81 | — | SHS | M47364100 |
| — | MEI PHARMA INC | 4,049,162 | $10,690 | 0.4% | $3.09 | — | COM NEW | 55279B202 |
| — | GRITSTONE ONCOLOGY INC | 2,695,418 | $10,620 | 0.4% | $3.94 | — | COM | 39868T105 |
| OVID | OVID THERAPEUTICS INC | 4,522,051 | $10,446 | 0.4% | $4.70 | -0.8% | COM | 690469101 |
| — | SELECTA BIOSCIENCES INC | 3,304,963 | $10,014 | 0.4% | $2.64 | — | COM | 816212104 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 4,012,404 | $9,710 | 0.4% | $3.93 | -42.0% | COM NEW | 372427401 |
| — | BCTG ACQUISITION CORP | 800,000 | $9,152 | 0.4% | $10.36 | — | COM | 05492W103 |
| — | CONTRAFECT CORP | 1,600,000 | $8,080 | 0.3% | $6.39 | — | COM NEW | 212326300 |
| — | CIDARA THERAPEUTICS INC | 3,739,704 | $7,479 | 0.3% | $3.06 | — | COM | 171757107 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,943,712 | $6,920 | 0.3% | $6.56 | -38.7% | COM | 221015100 |
| — | ERYTECH PHARMA | 625,000 | $6,119 | 0.2% | $22.02 | — | SPONSORED ADR | 29604W108 |
| — | GALMED PHARMACEUTICALS LTD | 1,799,694 | $5,597 | 0.2% | $11.58 | — | SHS | M47238106 |
| — | EUCRATES BIOMEDICAL ACQU COR | 500,000 | $5,330 | 0.2% | $10.66 | — | UNIT 10/23/2027 | G3141W114 |
| — | FRAZIER LIFESCIENCES ACQU CO | 500,000 | $5,205 | 0.2% | $10.41 | — | UNIT 12/09/2025 | G3710A121 |
| — | CURIS INC | 626,945 | $5,135 | 0.2% | $1.21 | — | COM NEW | 231269200 |
| — | X4 PHARMACEUTICALS INC | 792,892 | $5,098 | 0.2% | $12.84 | — | COM | 98420X103 |
| — | 5 01 ACQUISITION CORP | 500,000 | $5,085 | 0.2% | $10.17 | — | COM CL A | 33836P105 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 150,787 | $5,009 | 0.2% | $25.13 | +61.2% | COM | 71722W107 |
| — | REGULUS THERAPEUTICS INC | 3,376,207 | $4,558 | 0.2% | $0.80 | — | COM NEW | 75915K200 |
| — | FORWARD PHARMA A/S | 647,299 | $4,557 | 0.2% | $5.81 | — | SPONSORD ADS NEW | 34986J204 |
| — | SUNESIS PHARMACEUTICALS INC | 1,727,308 | $3,437 | 0.1% | $1.25 | — | COM NEW | 867328874 |
| — | JIYA ACQUISITION CORP | 300,000 | $3,090 | 0.1% | $10.30 | — | COM CL A | 47760M102 |
| RZLT | REZOLUTE INC | 190,814 | $2,357 | 0.1% | $19.25 | 0.0% | COM NEW | 76200L309 |
| — | LIFESCI ACQUISITION II CORP | 100,000 | $1,062 | 0.0% | $10.62 | — | COM | 53229E103 |
| — | F-STAR THERAPEUTICS INC | 25,844 | $255 | 0.0% | $9.87 | — | COM | 30315R107 |
| — | MIRAGEN THERAPEUTICS INC | 9,747 | $160 | 0.0% | $16.42 | — | COM NEW | 60463E202 |
| — | PANACEA ACQUISITION CORP | 9,837 | $126 | 0.0% | $12.00 | — | UNIT 99/99/9999 | 698102209 |
| — | SPRINGWORKS THERAPEUTICS INC | 50 | $4 | 0.0% | $22.96 | — | COM | 85205L107 |